Sussex Research Laboratories Inc. to Exhibit at TIDES USA 2023: Oligonucleotide & Peptide Therapeutics

Sussex Research Laboratories Inc., leading GalNAc and glycopeptide specialist, is excited to announce sponsorship of TIDES USA 2023: Oligonucleotide & Peptide Therapeutics. Visit us at booth 416 in San Diego, CA, USA and meet our CEO, Dr. Brady Clark, our VP of Chemistry, Dr. Fengyang Yan, our COO, Remmick So and our newly appointed Chief Scientific Officer, Dr. Corwin Nycholat.

For over 25 years, we have enabled application of complex carbohydrate systems, including GalNAc and glycopeptides, in drug discovery, drug delivery, drug targeting, glycoconjugate vaccine development, immunotherapy, therapeutic enhancement and diagnostic/bio-analytical assay development.